Reporter Tao Chunyan
As the bridgehead between Liaocheng and Jinan, and the “main battlefield” for ecological protection and high-quality development in the city’s Yellow River Basin, Dong’e focuses on industrial transformation. Upgrade and fully promote the quality and efficiency of the biopharmaceutical industry. After years of development, Dong’e currently has 10 pharmaceutical companies, of which China Resources Onde Biopharmaceutical Co., Ltd. has 3 new genetically engineered drugs, with an annual output of 4 million injections and 1 million powder injections. Pharmaceutical production enterprises achieved operating income of 3.55 billion yuan. The construction of China Resources Bio-Industrial Park and Ivy League has been accelerated, Chenkang Pharmaceutical and Aorun Pharmaceutical have been completed and put into operation, and projects such as Wuhan Hongtaokai Chondroitin Production Base have been signed and implemented. The biopharmaceutical industry is not only a pillar industry focused on by Liaocheng City, but also a leading industry of tens of billions of dollars that Dong’e County is striving to build.
On April 27, the Information Office of Liaocheng City People’s Government held a press conference. Axian’s measures to build a tens of billions of biopharmaceutical industry clusters in Luxi.
We will focus on cultivating and building leading enterprises in the industry. Firmly establish the concept of “project is king”, accelerate the construction of China Resources Bio-Industrial Park, build a bio-pharmaceutical production base with high standards and high quality, accelerate the establishment of China Resources’ bio-pharmaceutical brands in Dong’e, and realize Ruitongli, Jialinhao, Baijieyi, etc. Large-scale production of listed biopharmaceutical products. Gather various elements and resources, fully support the industrialization of EPO injection, dulaglutide and other biopharmaceutical products under development, and expand the biological drugs produced in Dong’e.
Concentrate on project construction and improve the industrial development platform. Strictly implement the “elements follow the project” mechanism, integrate land, capital and other elements of resources, fully support the construction of Chinese medicine big health industrial park, ivy industrial park and other projects, improve the park’s infrastructure and supporting facilities, and create a collection of research and development, production, sales and exhibition. An integrated biomedical incubation industrial park. Give full play to the role of the park as the main position in industrial development, make efforts to accelerate industrial agglomeration and innovative development, increase the attractiveness of biomedicine and related industries, and continue to expand the volume of the Chinese Medicine Health Industrial Park and Ivy League Industrial Park, in order to achieve biological The high-quality and leap-forward development of the pharmaceutical industry provides platform support.
Concentrate on transformation and upgrading to establish and improve the industrial chain. Relying on the production enterprises of Dong’e Ejiao, Guojiaotang Ejiao, Dongru Pharmaceutical and other drug brands, encourage enterprises to increase scientific and technological research and development efforts, and gradually realize the transformation of leading products from low-value-added food and health products to high-value-added drugs. Relying on key enterprises such as Ruisheng Pharmaceutical Excipients, Ahua Medical, Ahua Pharmaceutical Materials, etc., in the fields of pharmaceutical excipients, household medical devices, external packaging, etc., we will increase enterprise cultivation and foreign investment, and further enrich the biopharmaceutical industry system. Accelerate the construction of Dong’e cold chain logistics industrial park, carry out cloud warehousing and cloud services, and develop an intelligent and intelligent biomedical agglomeration area with fusion and fusion.
Together for win-win cooperation, deepen and expand foreign cooperation. Relying on key enterprises such as Chenkang Pharmaceutical and Aorun Pharmaceutical, we will increase the docking and cooperation with leading pharmaceutical enterprises such as Wuhan Hongtaokai and Guangzhou Baiyunshan, and guide enterprises to transform into pharmaceutical brand manufacturers. Do a good job in the development of the joint innovation zone with the China (Shandong) Free Trade Pilot Zone, increase the linkage between the Dong’e Economic Development Zone and the Jinan Area of the Free Trade Zone, and the Jining High-tech Industrial Development Zone Strengthen cooperation in the field, and create a new model of joint development of the traditional Chinese medicine industry. Give full play to the policy advantages of the free trade zone, and promote the international development of Dong’e traditional Chinese medicine “borrowing from Australia to go overseas” with the help of the Lu-Guangdong-Macao traditional Chinese medicine linkage innovation mechanism.